Paul F. Harron Jr. Lung Center

About the Paul F. Harron Jr. Lung Center

About Us

Your Life is Worth Penn Medicine

The Harron Lung Center offers a comprehensive approach to the diagnosis and treatment of lung disease. Penn's multidisciplinary team of expert clinicians and researchers has pioneered technological and treatment advances, providing patients with lung disease and lung cancer more leading-edge treatment options than any other provider in the region. All patient services, from imaging to rehabilitation, are conveniently located in one centralized location.

World-Class Patient Care & Research

  • Research has shown that for many lung diseases the best diagnosis is made when the pulmonologist, radiologist and pathologist work together to review symptoms and test results. Penn Medicine's state-of-the-art imaging and conference center facilitates onsite consultation between the pulmonary physicians, radiologists and pathologists. They work together to make the most accurate diagnosis for patients.
  • Penn Medicine's Thoracic Surgery Program is one of the largest and most active programs on the East Coast.
  • Penn thoracic surgeons work in close partnership with the cancer specialists at the Abramson Cancer Center to ensure lung cancer patients have integrated access to all cancer services and treatments in one convenient location.
  • Since the inception of the lung transplant program in 1991, Penn has changed the lives of nearly 750 lung transplant recipients and their loved ones. As one of the country's 10 most experienced centers, Penn Transplant Institute has achieved national and international recognition for contributions to the field of pulmonary transplantation.
  • Surgeons at Penn have performed more than double the number of lung transplants than any other transplant program in the Philadelphia region. The Penn Transplant Institute is also one of the few centers in the region to perform multiple organ transplants, such as heart-lung or liver-lung transplants.
  • Penn continues to be on the cutting edge of designing novel treatments for lung cancer, mesothelioma and pleural-related disorders.
  • Lung cancer researchers at Penn's Abramson Cancer Center are leaders in an international effort to revolutionize the prevention and management of lung cancer though the creation of the first international lung cancer registry. The registry's aim is to deepen the understanding of lung cancer at its earliest, most treatable stages.
  • Penn researchers have developed a treatment for mesothelioma based on work in the laboratory and continue to test its effectiveness through a National Cancer Institute grant.
  • Penn is a major center for lung cancer clinical trials, providing access to some of the newest and best therapies for patients.
  • Penn physicians are well represented in the latest edition of America's Top Doctors and are listed among the region's best in Philadelphia magazine's "Top Doctors" issue.
  • In 2013, U.S. News & World Report ranked the Hospital of the University of Pennsylvania eleventh in the nation for pulmonology.